KMBMEDIUM SIGNALFINANCIAL10-K

Kimberly-Clark reported broad-based financial declines with revenue falling 18% and operating income dropping 27% year-over-year.

The company experienced meaningful contractions across key operational metrics, suggesting either challenging market conditions or potential execution issues that require monitoring. The substantial reduction in share buybacks from $1.0B to $141M indicates management is prioritizing cash preservation over shareholder returns.

Comparing 2026-02-12 vs 2025-02-13View on EDGAR →
FINANCIAL ANALYSIS

KMB's financial performance weakened notably with revenue declining 18% to $16.4B and operating income falling 27% to $2.4B, while gross profit margins compressed. Despite the operational headwinds, stockholders' equity grew substantially to $1.5B, though this was accompanied by higher debt levels and reduced cash positions. The dramatic pullback in share repurchases suggests management is taking a more conservative capital allocation approach amid the challenging operating environment.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
-85.9%
$1.0B→$141.0M

Buyback activity reduced 85.9% — capital being redeployed elsewhere or cash conservation underway.

Stockholders Equity
Balance Sheet
+78.8%
$840.0M→$1.5B

Equity base grew 78.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Cash & Equivalents
Balance Sheet
-32.6%
$1.0B→$688.0M

Cash declined 32.6% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Operating Income
P&L
-26.8%
$3.2B→$2.4B

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Net Income
P&L
-20.6%
$2.5B→$2.0B

Net income declined 20.6% — review whether driven by operations, interest costs, or non-recurring items.

Inventory
Balance Sheet
-19%
$1.8B→$1.5B

Inventory reduced 19% — lean inventory management or demand outpacing supply.

Revenue
P&L
-18%
$20.1B→$16.4B

Revenue softened 18% — monitor whether this is cyclical or structural.

Gross Profit
P&L
-17.5%
$7.2B→$5.9B

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Operating Cash Flow
Cash Flow
-14.1%
$3.2B→$2.8B

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Total Debt
Balance Sheet
+10.4%
$6.7B→$7.4B

Debt rose 10.4% — additional borrowing for investment or operations; monitor coverage ratios.

LANGUAGE CHANGES
NEW — 2026-02-12
PRIOR — 2025-02-13
ADDED
As of January 30, 2026, there were 331,922,371 shares of Kimberly-Clark common stock outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 7A.
Form 10-K Summary 94 Signatures 95 KIMBERLY-CLARK CORPORATION - 2025 Annual Report PART I ITEM 1.
We are a global company focused on delivering essential products and solutions that solve unmet consumer needs and provide Better Care for a Better World.
Kimberly-Clark and our trusted brands are an indispensable part of life for people in more than 175 countries and territories.
Our portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, hold No.
2 share positions in approximately 70 countries and encompass five global daily-need product categories: Baby Child Care, Adult Care, Feminine Care, Family Care, and Professional.
We are committed to using sustainable practices that are designed to support a healthy planet, build strong communities, and enable our business to thrive for decades to come.
Recent Business Developments Pending Acquisition of Kenvue, Inc.
On November 2, 2025, we entered into an Agreement and Plan of Merger (the "Merger Agreement") to acquire the outstanding equity interests of Kenvue, Inc.
REMOVED
As of January 31, 2025, there were 331,684,601 shares of Kimberly-Clark common stock outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 7A.
Form 10-K Summary 81 Signature s 82 KIMBERLY-CLARK CORPORATION - 2024 Annual Report PART I ITEM 1.
We are a global company focused on delivering products and solutions that provide better care for a better world through product innovation and building o ur brands.
Fueled by ingenuity, creativity, and an understanding of people's most essential needs, we create products that help individuals experience more of what's important to them.
Our portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, encompass five global daily-need product categories: Baby Child Care, Adult Care, Feminine Care, Family Care, and Professional.
We strive to use sustainable practices that support a healthy planet, build strong communities, and ensure our business will thrive for decades to come.
Business Strategy and Segment Reporting During fiscal 2024, we announced our 2024 Transformation Initiative in order to create a more agile and focused operating structure that will accelerate our proprietary pipeline of innovation in right-to-win spaces and improve our growth trajectory, profitability, and returns on investment.
As part of this transformation, we realigned our internal operating and management structure to streamline our global supply chain and improve the efficiency of our corporate and regional overhead cost structures.
As a result of this realignment, we manage and report our operations through three reportable segments defined by geographic regions and product groupings: North America ("NA"), International Personal Care ("IPC") and International Family Care and Professional ("IFP").
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →